Bahuau M, Vidaud D, Jenkins RB, Bièche I, Kimmel DW, Assouline B et al (1998) Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 58:2298–2303

CAS  PubMed  Google Scholar 

Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA et al (2001) The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15:66–78. https://doi.org/10.1101/gad.186601

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caltabiano R, Magro G, Polizzi A, Pratico AD, Ortensi A, D’Orazi V et al (2017) A mosaic pattern of INI1/SMARCB1 protein expression distinguishes schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst 33:933–940. https://doi.org/10.1007/s00381-017-3340-2

Article  PubMed  Google Scholar 

Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S (2020) An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol 139:643–665. https://doi.org/10.1007/s00401-019-02029-5

Article  PubMed  Google Scholar 

Finzsch M, Schreiner S, Kichko T, Reeh P, Tamm ER, Bosl MR et al (2010) Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol 189:701–712. https://doi.org/10.1083/jcb.200912142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Helbing DL, Schulz A, Morrison H (2020) Pathomechanisms in schwannoma development and progression. Oncogene 39:5421–5429. https://doi.org/10.1038/s41388-020-1374-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805–810. https://doi.org/10.1086/513207

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S et al (2021) Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol 141:101–116. https://doi.org/10.1007/s00401-020-02230-x

Article  CAS  PubMed  Google Scholar 

Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L et al (2015) Expanding the mutational spectrum of LZTR1 in schwannomatosis. Eur J Hum Genet 23:963–968. https://doi.org/10.1038/ejhg.2014.220

Article  CAS  PubMed  Google Scholar 

Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P et al (2014) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46:182–187. https://doi.org/10.1038/ng.2855

Article  CAS  PubMed  Google Scholar 

Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med 24:1967–1977. https://doi.org/10.1016/j.gim.2022.05.007

Article  CAS  PubMed  Google Scholar 

Rivera B, Nadaf J, Fahiminiya S, Apellaniz-Ruiz M, Saskin A, Chong AS et al (2020) DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis. J Clin Invest 130:1479–1490. https://doi.org/10.1172/jci130206

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sargen MR, Kim J, Potjer TP, Velthuizen ME, Martir-Negron AE, Odia Y et al (2023) Estimated prevalence, tumor spectrum, and neurofibromatosis type 1-like phenotype of CDKN2A-related melanoma-astrocytoma syndrome. JAMA Dermatol. https://doi.org/10.1001/jamadermatol.2023.2621

Article  PubMed  Google Scholar 

Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L (2008) Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 29:227–231. https://doi.org/10.1002/humu.20679

Article  CAS  PubMed  Google Scholar 

Smith MJ, Wallace AJ, Bowers NL, Rustad CF, Woods CG, Leschziner GD et al (2012) Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics 13:141–145. https://doi.org/10.1007/s10048-012-0319-8

Article  CAS  PubMed  Google Scholar 

Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791–800. https://doi.org/10.1016/0092-8674(93)90501-g

Article  CAS  PubMed  Google Scholar 

Vasudevan HN, Lucas CG, Villanueva-Meyer JE, Theodosopoulos PV, Raleigh DR (2021) Genetic events and signaling mechanisms underlying Schwann cell fate in development and cancer. Neurosurgery 88:234–245. https://doi.org/10.1093/neuros/nyaa455

Article  PubMed  Google Scholar 

Williams EA, Ravindranathan A, Gupta R, Stevers NO, Suwala AK, Hong C et al (2023) Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. https://doi.org/10.1093/neuonc/noad121

Article  PubMed  PubMed Central  Google Scholar